^
    Apply
    A Phase 2 Clinical Study of ABSK061 and ABSK043 (NCT06632262)
    Phase 2
    Abbisko Therapeutics Co, Ltd
    Recruiting
    Last update posted :
    11/19/2024
    Initiation :
    11/13/2024
    Primary completion :
    11/30/2029
    Completion :
    06/30/2030
    HER-2 • FGFR2 • FGFR3
    |
    ABSK043 • ABSK061
    A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK061 in Patients With Advanced Solid Tumors (NCT05244551)
    Phase 1
    Abbisko Therapeutics Co, Ltd
    Recruiting
    Last update posted :
    11/16/2022
    Initiation :
    06/30/2022
    Primary completion :
    04/30/2025
    Completion :
    04/30/2025
    FGFR2
    |
    FGFR2 mutation • FGFR2 fusion • FGFR3 mutation • FGFR3 fusion
    |
    ABSK061